{"transactions":[{"id":717679,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-07-02T20:21:43.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":26066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units (\"RSU\") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027."}],"balance_after":26066,"source":{"system":"sec-edgar","filing":"0001401914-26-000037","document":"wk-form4_1783023698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191426000037/wk-form4_1783023698.xml","form_type":"4"}},{"id":717678,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-07-02T20:21:34.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":23696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units (\"RSU\") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027."}],"balance_after":23696,"source":{"system":"sec-edgar","filing":"0001401914-26-000036","document":"wk-form4_1783023690.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191426000036/wk-form4_1783023690.xml","form_type":"4"}},{"id":717676,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-07-02T20:21:26.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":30805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units (\"RSU\") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027."}],"balance_after":30847,"source":{"system":"sec-edgar","filing":"0001401914-26-000035","document":"wk-form4_1783023684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191426000035/wk-form4_1783023684.xml","form_type":"4"}},{"id":717677,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-07-02T20:21:20.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":38862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units (\"RSU\") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027."}],"balance_after":39721,"source":{"system":"sec-edgar","filing":"0001401914-26-000034","document":"wk-form4_1783023676.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191426000034/wk-form4_1783023676.xml","form_type":"4"}},{"id":717675,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-07-02T20:14:59.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":26540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units (\"RSU\") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027."}],"balance_after":47055,"source":{"system":"sec-edgar","filing":"0001301008-26-000004","document":"wk-form4_1783023293.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000130100826000004/wk-form4_1783023293.xml","form_type":"4"}},{"id":741492,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T21:05:28.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":10000,"derivative":{"exercise_price":2.03,"expiration_date":"2036-06-11","underlying":"Common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001205903-26-000005","document":"wk-form4_1781211925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120590326000005/wk-form4_1781211925.xml","form_type":"4"}},{"id":741489,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T21:03:40.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":10000,"derivative":{"exercise_price":2.03,"expiration_date":"2036-06-11","underlying":"Common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001519612-26-000002","document":"wk-form4_1781211817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000151961226000002/wk-form4_1781211817.xml","form_type":"4"}},{"id":741490,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:58:47.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":10000,"derivative":{"exercise_price":2.03,"expiration_date":"2036-06-11","underlying":"Common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001301008-26-000002","document":"wk-form4_1781211524.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000130100826000002/wk-form4_1781211524.xml","form_type":"4"}},{"id":741488,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:52:10.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":10000,"derivative":{"exercise_price":2.03,"expiration_date":"2036-06-11","underlying":"Common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001536574-26-000002","document":"wk-form4_1781211127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000153657426000002/wk-form4_1781211127.xml","form_type":"4"}},{"id":741485,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:47:59.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":10000,"derivative":{"exercise_price":2.03,"expiration_date":"2036-06-11","underlying":"Common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001736781-26-000002","document":"wk-form4_1781210876.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000173678126000002/wk-form4_1781210876.xml","form_type":"4"}},{"id":890536,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2026-02-20T21:01:50.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":21600,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This date is the date on which the reporting person subscribed to purchase the securities. The securities will be issued at a future date when the Issuer accepts the reporting person's subscription."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 10,800 Investor Units (the Units) purchased by the reporting person in the Regulation A offering of the Issuer for $5 per Unit. Each Unit consists of one share of Preferred Stock, each of which is initially convertible into two shares of Common Stock, and two warrants, each to purchase one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This security is convertible or exercisable, as applicable, at any time after issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This security expires on the 36-month anniversary of the date of issuance."}],"balance_after":21600,"derivative":{"exercise_price":4,"underlying":"Common stock","underlying_shares":21600},"source":{"system":"sec-edgar","filing":"0001199102-26-000004","document":"wk-form4_1771621308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000119910226000004/wk-form4_1771621308.xml","form_type":"4"}},{"id":890535,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-02-20T21:01:50.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":10800,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This date is the date on which the reporting person subscribed to purchase the securities. The securities will be issued at a future date when the Issuer accepts the reporting person's subscription."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 10,800 Investor Units (the Units) purchased by the reporting person in the Regulation A offering of the Issuer for $5 per Unit. Each Unit consists of one share of Preferred Stock, each of which is initially convertible into two shares of Common Stock, and two warrants, each to purchase one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This security is convertible or exercisable, as applicable, at any time after issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A Convertible Preferred Stock (the Preferred Stock) is perpetual and has no expiration date. The Issuer has the option to redeem the Preferred Stock and the right to require the conversion of the Preferred Stock into shares of the common stock of the Issuer (the Common Stock), in each case, subject to specified conditions."}],"balance_after":10800,"derivative":{"exercise_price":2.5,"underlying":"Common stock","underlying_shares":21600},"source":{"system":"sec-edgar","filing":"0001199102-26-000004","document":"wk-form4_1771621308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000119910226000004/wk-form4_1771621308.xml","form_type":"4"}},{"id":924772,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-02T21:06:47.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":172000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":172000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-01-30","underlying":"Common stock","underlying_shares":172000},"source":{"system":"sec-edgar","filing":"0001199102-26-000002","document":"wk-form4_1770066405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000119910226000002/wk-form4_1770066405.xml","form_type":"4"}},{"id":924771,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":68205,"kind":"person","name":"Haring-Layton MarDee","position":1,"cik":"0001535596","reported_name":"Haring-Layton MarDee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-02T21:05:49.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":49000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-01-30","underlying":"Common stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001535596-26-000002","document":"wk-form4_1770066346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000153559626000002/wk-form4_1770066346.xml","form_type":"4"}},{"id":1047744,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":68205,"kind":"person","name":"Haring-Layton MarDee","position":1,"cik":"0001535596","reported_name":"Haring-Layton MarDee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-04T21:59:23.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was granted to the reporting person as a retention award and vests and becomes exercisable on 9/4/2027, provided, that, if certain performance criteria are satisfied, it will vest and become exercisable on the date such performance criteria are satisfied, subject to the reporting person's continuous service to the issuer."}],"balance_after":57000,"derivative":{"exercise_price":2.13,"expiration_date":"2035-09-04","underlying":"Common stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001401914-25-000046","document":"wk-form4_1757023159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000046/wk-form4_1757023159.xml","form_type":"4"}},{"id":1089229,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:05:59.000Z","date":"2025-07-09","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":4500,"derivative":{"exercise_price":2.44,"expiration_date":"2035-07-09","underlying":"Common stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001401914-25-000040","document":"wk-form4_1752177952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000040/wk-form4_1752177952.xml","form_type":"4"}},{"id":1089230,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:05:47.000Z","date":"2025-07-09","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":4500,"derivative":{"exercise_price":2.44,"expiration_date":"2035-07-09","underlying":"Common stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001401914-25-000039","document":"wk-form4_1752177941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000039/wk-form4_1752177941.xml","form_type":"4"}},{"id":1089228,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:05:37.000Z","date":"2025-07-09","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":4500,"derivative":{"exercise_price":2.44,"expiration_date":"2035-07-09","underlying":"Common stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001401914-25-000038","document":"wk-form4_1752177931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000038/wk-form4_1752177931.xml","form_type":"4"}},{"id":1089227,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:05:27.000Z","date":"2025-07-09","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":4500,"derivative":{"exercise_price":2.44,"expiration_date":"2035-07-09","underlying":"Common stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001401914-25-000037","document":"wk-form4_1752177920.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000037/wk-form4_1752177920.xml","form_type":"4"}},{"id":1089224,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:05:18.000Z","date":"2025-07-09","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":4500,"derivative":{"exercise_price":2.44,"expiration_date":"2035-07-09","underlying":"Common stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001401914-25-000036","document":"wk-form4_1752177909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000036/wk-form4_1752177909.xml","form_type":"4"}},{"id":1289339,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":68205,"kind":"person","name":"Haring-Layton MarDee","position":1,"cik":"0001535596","reported_name":"Haring-Layton MarDee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-31T22:34:13.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":38000,"derivative":{"exercise_price":3.27,"expiration_date":"2035-01-28","underlying":"Common stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001401914-25-000006","document":"wk-form4_1738362847.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000006/wk-form4_1738362847.xml","form_type":"4"}},{"id":1289338,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-31T22:31:46.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":107000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":107000,"derivative":{"exercise_price":3.27,"expiration_date":"2035-01-28","underlying":"Common stock","underlying_shares":107000},"source":{"system":"sec-edgar","filing":"0001401914-25-000004","document":"wk-form4_1738362699.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000004/wk-form4_1738362699.xml","form_type":"4"}},{"id":1486569,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T21:15:40.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.43,"expiration_date":"2034-06-05","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-023181","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224023181/ownership.xml","form_type":"4"}},{"id":1486570,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T21:15:38.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.43,"expiration_date":"2034-06-05","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-023180","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224023180/ownership.xml","form_type":"4"}},{"id":1486568,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T21:15:37.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.43,"expiration_date":"2034-06-05","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-023179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224023179/ownership.xml","form_type":"4"}},{"id":1486566,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T21:15:35.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.43,"expiration_date":"2034-06-05","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-023178","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224023178/ownership.xml","form_type":"4"}},{"id":1486567,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T21:15:33.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.43,"expiration_date":"2034-06-05","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-023177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224023177/ownership.xml","form_type":"4"}},{"id":1576478,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":93041,"kind":"person","name":"Fair John A","position":1,"cik":"0001739140","reported_name":"Fair John A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-14T20:39:13.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":290000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-03-12","underlying":"Common stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001401914-24-000008","document":"wk-form4_1710448743.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191424000008/wk-form4_1710448743.xml","form_type":"4"}},{"id":1576477,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-14T20:34:04.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":750000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-03-12","underlying":"Common stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001401914-24-000006","document":"wk-form4_1710448428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191424000006/wk-form4_1710448428.xml","form_type":"4"}},{"id":1576476,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":68205,"kind":"person","name":"Haring-Layton MarDee","position":1,"cik":"0001535596","reported_name":"Haring-Layton MarDee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-14T20:28:11.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":290000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-03-12","underlying":"Common stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001401914-24-000004","document":"wk-form4_1710448076.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191424000004/wk-form4_1710448076.xml","form_type":"4"}},{"id":1847703,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-22T01:48:21.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.96,"expiration_date":"2033-06-21","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001401914-23-000038","document":"wk-form4_1687398491.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000038/wk-form4_1687398491.xml","form_type":"4"}},{"id":1847702,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-22T01:46:34.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.96,"expiration_date":"2033-06-21","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001401914-23-000036","document":"wk-form4_1687398384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000036/wk-form4_1687398384.xml","form_type":"4"}},{"id":1847701,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-22T01:45:00.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.96,"expiration_date":"2033-06-21","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001401914-23-000034","document":"wk-form4_1687398288.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000034/wk-form4_1687398288.xml","form_type":"4"}},{"id":1847700,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":112054,"kind":"person","name":"Ononye-Onyia Sophia Nnenna","position":1,"cik":"0001857183","reported_name":"Ononye-Onyia Sophia Nnenna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-22T01:43:17.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.96,"expiration_date":"2033-06-21","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001401914-23-000032","document":"wk-form4_1687398187.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000032/wk-form4_1687398187.xml","form_type":"4"}},{"id":1847699,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-22T01:41:31.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.96,"expiration_date":"2033-06-21","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001401914-23-000030","document":"wk-form4_1687398083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000030/wk-form4_1687398083.xml","form_type":"4"}},{"id":1847698,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-22T01:39:48.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.96,"expiration_date":"2033-06-21","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001401914-23-000028","document":"wk-form4_1687397979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000028/wk-form4_1687397979.xml","form_type":"4"}},{"id":1847697,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-22T01:38:14.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":40000,"derivative":{"exercise_price":0.96,"expiration_date":"2033-06-21","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001401914-23-000026","document":"wk-form4_1687397884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000026/wk-form4_1687397884.xml","form_type":"4"}},{"id":2044897,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-26T21:07:34.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":750000,"derivative":{"exercise_price":1.16,"expiration_date":"2033-01-24","underlying":"Common stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001401914-23-000008","document":"wf-form4_167476720939649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000008/wf-form4_167476720939649.xml","form_type":"4"}},{"id":2044896,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-26T21:06:19.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":290000,"derivative":{"exercise_price":1.16,"expiration_date":"2033-01-24","underlying":"Common stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001401914-23-000007","document":"wf-form4_167476716272724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000007/wf-form4_167476716272724.xml","form_type":"4"}},{"id":2044895,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":93041,"kind":"person","name":"Fair John A","position":1,"cik":"0001739140","reported_name":"Fair John A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-26T21:05:36.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":290000,"derivative":{"exercise_price":1.16,"expiration_date":"2033-01-24","underlying":"Common stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001401914-23-000006","document":"wf-form4_167476712040761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000006/wf-form4_167476712040761.xml","form_type":"4"}},{"id":2221928,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:52:30.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":38000,"derivative":{"exercise_price":1.31,"expiration_date":"2032-06-23","underlying":"Common stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001401914-22-000071","document":"wf-form4_165610393127419.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000071/wf-form4_165610393127419.xml","form_type":"4"}},{"id":2221926,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:51:05.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":38000,"derivative":{"exercise_price":1.31,"expiration_date":"2032-06-23","underlying":"Common stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001401914-22-000070","document":"wf-form4_165610383624225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000070/wf-form4_165610383624225.xml","form_type":"4"}},{"id":2221927,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:49:35.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":38000,"derivative":{"exercise_price":1.31,"expiration_date":"2032-06-23","underlying":"Common stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001401914-22-000069","document":"wf-form4_165610375926172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000069/wf-form4_165610375926172.xml","form_type":"4"}},{"id":2221925,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":112054,"kind":"person","name":"Ononye-Onyia Sophia Nnenna","position":1,"cik":"0001857183","reported_name":"Ononye-Onyia Sophia Nnenna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:47:28.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":38000,"derivative":{"exercise_price":1.31,"expiration_date":"2032-06-23","underlying":"Common stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001401914-22-000068","document":"wf-form4_165610363504669.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000068/wf-form4_165610363504669.xml","form_type":"4"}},{"id":2221924,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:30:08.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":38000,"derivative":{"exercise_price":1.31,"expiration_date":"2032-06-23","underlying":"Common stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001401914-22-000062","document":"wf-form4_165610257799601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000062/wf-form4_165610257799601.xml","form_type":"4"}},{"id":2221923,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:18:55.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":38000,"derivative":{"exercise_price":1.31,"expiration_date":"2032-06-23","underlying":"Common stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001401914-22-000060","document":"wf-form4_165610191903120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000060/wf-form4_165610191903120.xml","form_type":"4"}},{"id":2221922,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:03:59.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":38000,"derivative":{"exercise_price":1.31,"expiration_date":"2032-06-23","underlying":"Common stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001401914-22-000056","document":"wf-form4_165610102252631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000056/wf-form4_165610102252631.xml","form_type":"4"}},{"id":2422382,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":93041,"kind":"person","name":"Fair John A","position":1,"cik":"0001739140","reported_name":"Fair John A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T21:05:38.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":185000,"derivative":{"exercise_price":1.59,"expiration_date":"2032-01-25","underlying":"Common stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001401914-22-000009","document":"wf-form4_164340390259574.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000009/wf-form4_164340390259574.xml","form_type":"4"}},{"id":2422380,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T21:04:13.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":628400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":628400,"derivative":{"exercise_price":1.59,"expiration_date":"2032-01-25","underlying":"Common stock","underlying_shares":628400},"source":{"system":"sec-edgar","filing":"0001401914-22-000008","document":"wf-form4_164340383866492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000008/wf-form4_164340383866492.xml","form_type":"4"}},{"id":2422377,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T21:02:24.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":185000,"derivative":{"exercise_price":1.59,"expiration_date":"2032-01-25","underlying":"Common stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001401914-22-000007","document":"wf-form4_164340372783895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000007/wf-form4_164340372783895.xml","form_type":"4"}},{"id":2655735,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-24T21:00:56.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":30000,"derivative":{"exercise_price":1.46,"expiration_date":"2031-06-24","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001401914-21-000103","document":"wf-form4_162456842200952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191421000103/wf-form4_162456842200952.xml","form_type":"4"}},{"id":2655734,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-24T20:56:43.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":30000,"derivative":{"exercise_price":1.46,"expiration_date":"2031-06-24","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001401914-21-000101","document":"wf-form4_162456818462982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191421000101/wf-form4_162456818462982.xml","form_type":"4"}},{"id":2655732,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-24T20:51:10.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":30000,"derivative":{"exercise_price":1.46,"expiration_date":"2031-06-24","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001401914-21-000098","document":"wf-form4_162456781006637.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191421000098/wf-form4_162456781006637.xml","form_type":"4"}},{"id":2655733,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-24T20:43:53.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":30000,"derivative":{"exercise_price":1.46,"expiration_date":"2031-06-24","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001401914-21-000094","document":"wf-form4_162456741352719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191421000094/wf-form4_162456741352719.xml","form_type":"4"}},{"id":2655730,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-24T20:40:52.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":30000,"derivative":{"exercise_price":1.46,"expiration_date":"2031-06-24","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001401914-21-000092","document":"wf-form4_162456719866945.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191421000092/wf-form4_162456719866945.xml","form_type":"4"}},{"id":2655731,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-24T20:35:21.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":30000,"derivative":{"exercise_price":1.46,"expiration_date":"2031-06-24","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001401914-21-000090","document":"wf-form4_162456686646072.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191421000090/wf-form4_162456686646072.xml","form_type":"4"}},{"id":2743911,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":112054,"kind":"person","name":"Ononye-Onyia Sophia Nnenna","position":1,"cik":"0001857183","reported_name":"Ononye-Onyia Sophia Nnenna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-20T20:05:28.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/3rd of the shares subject to this option on each of the first three anniversaries of the transaction date, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.4,"expiration_date":"2031-04-16","underlying":"Common stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001401914-21-000068","document":"wf-form4_161894910752094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191421000068/wf-form4_161894910752094.xml","form_type":"4"}},{"id":2892028,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":93041,"kind":"person","name":"Fair John A","position":1,"cik":"0001739140","reported_name":"Fair John A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T21:17:41.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":168000,"derivative":{"exercise_price":2.59,"expiration_date":"2031-01-26","underlying":"Common stock","underlying_shares":168000},"source":{"system":"sec-edgar","filing":"0001739140-21-000002","document":"wf-form4_161186864677254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000173914021000002/wf-form4_161186864677254.xml","form_type":"4"}},{"id":2892026,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T21:13:41.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":168000,"derivative":{"exercise_price":2.59,"expiration_date":"2031-01-26","underlying":"Common stock","underlying_shares":168000},"source":{"system":"sec-edgar","filing":"0001711576-21-000002","document":"wf-form4_161186841012861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000171157621000002/wf-form4_161186841012861.xml","form_type":"4"}},{"id":2892027,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T21:05:19.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":525000,"derivative":{"exercise_price":2.59,"expiration_date":"2031-01-26","underlying":"Common stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001199102-21-000005","document":"wf-form4_161186790314013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000119910221000005/wf-form4_161186790314013.xml","form_type":"4"}},{"id":3098398,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-27T00:57:00.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":1.03,"expiration_date":"2030-06-25","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001401914-20-000098","document":"wf-form4_159321940289407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000098/wf-form4_159321940289407.xml","form_type":"4"}},{"id":3098397,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-27T00:56:38.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":1.03,"expiration_date":"2030-06-25","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001401914-20-000097","document":"wf-form4_159321937668046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000097/wf-form4_159321937668046.xml","form_type":"4"}},{"id":3098395,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-27T00:56:12.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":1.03,"expiration_date":"2030-06-25","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001401914-20-000096","document":"wf-form4_159321935213925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000096/wf-form4_159321935213925.xml","form_type":"4"}},{"id":3098393,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-27T00:55:47.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":1.03,"expiration_date":"2030-06-25","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001401914-20-000095","document":"wf-form4_159321932732948.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000095/wf-form4_159321932732948.xml","form_type":"4"}},{"id":3098391,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-27T00:55:23.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":1.03,"expiration_date":"2030-06-25","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001401914-20-000094","document":"wf-form4_159321930436873.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000094/wf-form4_159321930436873.xml","form_type":"4"}},{"id":3098390,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-27T00:55:00.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":1.03,"expiration_date":"2030-06-25","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001401914-20-000093","document":"wf-form4_159321928214573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000093/wf-form4_159321928214573.xml","form_type":"4"}},{"id":3220261,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":93041,"kind":"person","name":"Fair John A","position":1,"cik":"0001739140","reported_name":"Fair John A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-09T21:47:49.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":68000,"derivative":{"exercise_price":1.03,"expiration_date":"2030-03-06","underlying":"Common stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001401914-20-000036","document":"wf-form4_158379045238597.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000036/wf-form4_158379045238597.xml","form_type":"4"}},{"id":3220260,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-09T21:43:58.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":280000,"derivative":{"exercise_price":1.03,"expiration_date":"2030-03-06","underlying":"Common stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001401914-20-000034","document":"wf-form4_158379021939186.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000034/wf-form4_158379021939186.xml","form_type":"4"}},{"id":3220259,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-09T21:42:19.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":68000,"derivative":{"exercise_price":1.03,"expiration_date":"2030-03-06","underlying":"Common stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001401914-20-000032","document":"wf-form4_158379012050278.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000032/wf-form4_158379012050278.xml","form_type":"4"}},{"id":3362886,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T00:55:16.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/3rd of the shares subject to this option on each of the first three anniversaries of the transaction date, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.79,"expiration_date":"2029-11-20","underlying":"Common stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001401914-19-000100","document":"wf-form4_157438410017998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191419000100/wf-form4_157438410017998.xml","form_type":"4"}},{"id":3489413,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T18:35:08.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":0.9,"expiration_date":"2029-06-13","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001401914-19-000066","document":"wf-form4_156053729327372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191419000066/wf-form4_156053729327372.xml","form_type":"4"}},{"id":3489412,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T18:33:30.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":0.9,"expiration_date":"2029-06-13","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001401914-19-000064","document":"wf-form4_156053719512628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191419000064/wf-form4_156053719512628.xml","form_type":"4"}},{"id":3489411,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T18:31:03.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":0.9,"expiration_date":"2029-06-13","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001401914-19-000062","document":"wf-form4_156053704682456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191419000062/wf-form4_156053704682456.xml","form_type":"4"}},{"id":3489503,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T11:08:47.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":0.9,"expiration_date":"2029-06-13","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001736781-19-000001","document":"wf-form4_156051051083771.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000173678119000001/wf-form4_156051051083771.xml","form_type":"4"}},{"id":3489410,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T11:04:55.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":0.9,"expiration_date":"2029-06-13","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001536574-19-000001","document":"wf-form4_156051028016144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000153657419000001/wf-form4_156051028016144.xml","form_type":"4"}},{"id":3489409,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":156699,"kind":"person","name":"HAWLEY ROGER","position":1,"cik":"0001257386","reported_name":"HAWLEY ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T11:01:39.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer."}],"balance_after":22500,"derivative":{"exercise_price":0.9,"expiration_date":"2029-06-13","underlying":"Common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001257386-19-000007","document":"wf-form4_156051008272911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000125738619000007/wf-form4_156051008272911.xml","form_type":"4"}},{"id":3555804,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":156699,"kind":"person","name":"HAWLEY ROGER","position":1,"cik":"0001257386","reported_name":"HAWLEY ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-04-15T20:25:52.000Z","date":"2019-04-11","kind":"purchase","acquired":true,"shares":454545,"price":1.1,"value":499999.5,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities were purchased by the reporting person in the underwritten public offering of the issuer which closed on April 11, 2019. The reported securities are held in The Hawley Family Trust Dated October 22, 2004, of which the reporting person is the trustee."}],"balance_after":944956,"source":{"system":"sec-edgar","filing":"0001257386-19-000005","document":"wf-form4_155535993775373.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000125738619000005/wf-form4_155535993775373.xml","form_type":"4"}},{"id":3681160,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-31T22:30:56.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":75000,"derivative":{"exercise_price":0.759,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-19-006217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919119006217/doc4.xml","form_type":"4"}},{"id":3681159,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-31T22:30:03.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":195000,"derivative":{"exercise_price":0.759,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001209191-19-006215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919119006215/doc4.xml","form_type":"4"}},{"id":3814149,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32780,"kind":"person","name":"Matz Gregory W","position":1,"cik":"0001536574","reported_name":"Matz Gregory W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-09-17T21:45:32.000Z","date":"2018-09-13","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/3rd of the shares subject to this option on each of the first three anniversaries of the transaction date, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.03,"expiration_date":"2028-09-13","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-051267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118051267/doc4.xml","form_type":"4"}},{"id":3820487,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-09-10T22:23:39.000Z","date":"2018-09-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock options vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":100000,"derivative":{"exercise_price":1.01,"expiration_date":"2028-09-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-050351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118050351/doc4.xml","form_type":"4"}},{"id":3820486,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-09-10T22:22:44.000Z","date":"2018-09-07","kind":"grant","acquired":true,"shares":192000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock options vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":192000,"derivative":{"exercise_price":1.01,"expiration_date":"2028-09-07","underlying":"Common Stock","underlying_shares":192000},"source":{"system":"sec-edgar","filing":"0001209191-18-050350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118050350/doc4.xml","form_type":"4"}},{"id":3869211,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":156699,"kind":"person","name":"HAWLEY ROGER","position":1,"cik":"0001257386","reported_name":"HAWLEY ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-11T21:52:51.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.35,"expiration_date":"2028-07-10","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-042387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118042387/doc4.xml","form_type":"4"}},{"id":3869210,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-11T21:46:10.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.35,"expiration_date":"2028-07-10","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-042386","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118042386/doc4.xml","form_type":"4"}},{"id":3869208,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-11T21:45:31.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.35,"expiration_date":"2028-07-10","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-042385","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118042385/doc4.xml","form_type":"4"}},{"id":3869209,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-11T21:44:44.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.35,"expiration_date":"2028-07-10","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-042384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118042384/doc4.xml","form_type":"4"}},{"id":3869207,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32783,"kind":"person","name":"Grossman Jessica D.","position":1,"cik":"0001736781","reported_name":"Grossman Jessica D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-11T21:42:23.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.35,"expiration_date":"2028-07-10","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-042381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118042381/doc4.xml","form_type":"4"}},{"id":3896620,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":156699,"kind":"person","name":"HAWLEY ROGER","position":1,"cik":"0001257386","reported_name":"HAWLEY ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-12T22:30:49.000Z","date":"2018-06-11","kind":"purchase","acquired":true,"shares":140000,"price":1.4527,"value":203378.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average. This transaction was executed in multiple trades at prices ranging from $1.385 to $1.48. The reporting person undertakes to provide full information regarding the number of shares and prices at which the trades were effected upon request to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission."}],"balance_after":140000,"source":{"system":"sec-edgar","filing":"0001209191-18-037306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118037306/doc4.xml","form_type":"4"}},{"id":4137791,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-12-08T21:08:10.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Rastetter was awarded options to purchase shares of the Corporation's common stock in connection with his service as a member of the Board of Directors (the \"Director Options\") pursuant to the Corporation's 2014 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This form amends a Form 4 previously filed for Dr. Rastetter on July 21, 2017, to correct the description of the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Director Options will vest in full on the earlier of the one year anniversary of the date of grant or immediately prior to the Corporation's 2018 annual meeting of stockholders."}],"balance_after":2000,"derivative":{"exercise_price":6.56,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-17-064688","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117064688/doc4a.xml","form_type":"4/A","original_submission_date":"2017-07-21"}},{"id":4137790,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-12-08T21:07:18.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Kelley was awarded options to purchase shares of the Corporation's common stock in connection with her service as a member of the Board of Directors (the \"Director Options\") pursuant to the Corporation's 2014 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Director Options will vest in full on the earlier of the one year anniversary of the date of grant or immediately prior to the Corporation's 2018 annual meeting of stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This form amends a Form 4 previously filed for Dr. Kelley on July 21, 2017, to correct the description of the vesting schedule of the stock options."}],"balance_after":2000,"derivative":{"exercise_price":6.56,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-17-064686","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117064686/doc4a.xml","form_type":"4/A","original_submission_date":"2017-07-21"}},{"id":4251819,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-07-25T20:20:28.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":962062,"ownership":{"direct":false,"nature":"By The Vincent S. Johnson and Sabrina M. Johnson Family Trust Dated February 4, 2005"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the \"Corporation\"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. (\"Dare Operations\") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the \"Transaction\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 4,739,295 shares of Dare Operations common stock. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis)."}],"balance_after":962062,"source":{"system":"sec-edgar","filing":"0001209191-17-046159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117046159/doc4.xml","form_type":"4"}},{"id":4253197,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-07-21T21:21:00.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Kelley was awarded options to purchase shares of the Corporation's common stock in connection with her service as a member of the Board of Directors (the \"Director Options\") pursuant to the Corporation's 2014 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Director Options will vest in equal annual installments over a three-year period measured from the date of grant, subject to Dr. Kelley's continued service to the Corporation and will become exercisable in full upon a change of control of the Corporation."}],"balance_after":2000,"derivative":{"exercise_price":6.56,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-17-046001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117046001/doc4.xml","form_type":"4"}},{"id":4253195,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32781,"kind":"person","name":"RASTETTER WILLIAM H","position":1,"cik":"0001205903","reported_name":"RASTETTER WILLIAM H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-07-21T21:15:39.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Rastetter was awarded options to purchase shares of the Corporation's common stock in connection with his service as a member of the Board of Directors (the \"Director Options\") pursuant to the Corporation's 2014 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Director Options will vest in equal annual installments over a three-year period measured from the date of grant, subject to Dr. Rastetter's continued service to the Corporation and will become exercisable in full upon a change of control of the Corporation."}],"balance_after":2000,"derivative":{"exercise_price":6.56,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-17-045998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117045998/doc4.xml","form_type":"4"}},{"id":4253196,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-21T21:12:34.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":443512,"ownership":{"direct":false,"nature":"By The Lisa Walters-Hoffert Survivor's Trust dated October 31, 2002"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the \"Corporation\"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. (\"Dare Operations\") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the \"Transaction\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares were received in connection with the Transaction in exchange for 2,184,823 shares of Dare Operations common stock. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis)."}],"balance_after":443512,"source":{"system":"sec-edgar","filing":"0001209191-17-045994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117045994/doc4.xml","form_type":"4"}},{"id":4253194,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-07-21T21:03:29.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017."},{"field":"shares","element":"transactionShares","label":"F4","text":"Ms. Steele was awarded options to purchase shares of the Corporation's common stock in connection with her service as a member of the Board of Directors (the \"Director Options\") pursuant to the Corporation's 2014 Stock Incentive Plan and the Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Director Options will vest in equal annual installments over a three-year period measured from the date of grant, subject to Ms. Steele's continued service to the Corporation and will become exercisable in full upon a change of control of the Corporation."}],"balance_after":2200,"derivative":{"exercise_price":6.56,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":2200},"source":{"system":"sec-edgar","filing":"0001209191-17-045984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117045984/doc4.xml","form_type":"4"}},{"id":4253193,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":32779,"kind":"person","name":"Steele Robin Joan","position":1,"cik":"0001301008","reported_name":"Steele Robin Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-21T21:03:29.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":246171,"ownership":{"direct":false,"nature":"By The Robin J. Steele Trust DTD 1/30/2015"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the \"Corporation\"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. (\"Dare Operations\") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the \"Transaction\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 1,212,685 shares of Dare Operations. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis)."}],"balance_after":246171,"source":{"system":"sec-edgar","filing":"0001209191-17-045984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117045984/doc4.xml","form_type":"4"}},{"id":4253192,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":156699,"kind":"person","name":"HAWLEY ROGER","position":1,"cik":"0001257386","reported_name":"HAWLEY ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-07-21T20:09:53.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017."},{"field":"shares","element":"transactionShares","label":"F7","text":"Mr. Hawley was awarded options to purchase shares of the Corporation's common stock in connection with his service as a member of the Board of Directors (the \"Director Options\") pursuant to the Corporation's 2014 Stock Incentive Plan and the Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Director Options will vest in equal annual installments over a three year period measured from the date of grant, subject to Mr. Hawley's continued service to the Corporation, and will become exercisable in full upon a change of control of the Corporation."}],"balance_after":2200,"derivative":{"exercise_price":6.56,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":2200},"source":{"system":"sec-edgar","filing":"0001209191-17-045934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117045934/doc4.xml","form_type":"4"}},{"id":4253191,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":156699,"kind":"person","name":"HAWLEY ROGER","position":1,"cik":"0001257386","reported_name":"HAWLEY ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-07-21T20:09:53.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":10149,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the \"Corporation\"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. (\"Dare Operations\") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the \"Transaction\")."},{"field":"shares","element":"transactionShares","label":"F4","text":"The shares of common stock of the Corporation excercisable pursuant to the option reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These options to purchase common stock of the Corporation were received in connection with the Transaction in exchange for 50,000 options to purchase shares of common stock of Dare Operations.  Each option to purchase one share of common stock of Dare Operations was cancelled and exchanged for the right to receive an option to purchase 0.2029969047 shares of common stock of the Corporation (on a post-split basis)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock of the Corporation excercisable pursuant to the option reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These options to purchase common stock of the Corporation were received in connection with the Transaction in exchange for 50,000 options to purchase shares of common stock of Dare Operations.  Each option to purchase one share of common stock of Dare Operations was cancelled and exchanged for the right to receive an option to purchase 0.2029969047 shares of common stock of the Corporation (on a post-split basis)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Commencing on May 28, 2015 (the \"Vesting Start Date\"), Mr. Hawley shall acquire a vested interest in the shares of common stock of the Corporation exercisable pursuant to the option in a series of three (3) successive annual installments on the yearly anniversary of the Vesting Start Date, subject to Mr. Hawley's continued service to the Corporation."}],"balance_after":10149,"derivative":{"exercise_price":0.005,"expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":10149},"source":{"system":"sec-edgar","filing":"0001209191-17-045934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117045934/doc4.xml","form_type":"4"}},{"id":4253190,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":156699,"kind":"person","name":"HAWLEY ROGER","position":1,"cik":"0001257386","reported_name":"HAWLEY ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-21T20:09:53.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":307714,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Hawley Family Trust Dated October 22, 2004"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the \"Corporation\"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. (\"Dare Operations\") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the \"Transaction\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 1,515,857 shares of Dare Operations common stock.  On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis).  Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis)."}],"balance_after":490411,"source":{"system":"sec-edgar","filing":"0001209191-17-045934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117045934/doc4.xml","form_type":"4"}},{"id":4253189,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":156699,"kind":"person","name":"HAWLEY ROGER","position":1,"cik":"0001257386","reported_name":"HAWLEY ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-21T20:09:53.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":182697,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the \"Corporation\"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. (\"Dare Operations\") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the \"Transaction\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 900,000 shares of Dare Operations common stock. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis)."}],"balance_after":182697,"source":{"system":"sec-edgar","filing":"0001209191-17-045934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117045934/doc4.xml","form_type":"4"}}],"next_cursor":"2017-07-21T20:09:53.000000Z,4253189"}